Two FDA Approvals Propel CAR T Cell Therapy Into the Limelight – Oncology Nurse Advisor
Oncology Nurse AdvisorTwo FDA Approvals Propel CAR T Cell Therapy Into the LimelightOncology Nurse AdvisorTisagenlecleucel, from Novartis Pharmaceuticals Corp, is the first chimeric antigen receptor (CAR) T cell immunotherapy to be granted approval. Th… Continue reading
